These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 32825009)

  • 1. A Systematic Review of Inverse Agonism at Adrenoceptor Subtypes.
    Michel MC; Michel-Reher MB; Hein P
    Cells; 2020 Aug; 9(9):. PubMed ID: 32825009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
    Baker JG
    Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechano-sensitivity of β2-adrenoceptors enhances constitutive activation of cAMP generation that is inhibited by inverse agonists.
    Cullum SA; Platt S; Dale N; Isaac OC; Wragg ES; Soave M; Veprintsev DB; Woolard J; Kilpatrick LE; Hill SJ
    Commun Biol; 2024 Apr; 7(1):417. PubMed ID: 38580813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis toxin suppresses carbachol-evoked cardiodepression but does not modify cardiostimulation mediated through beta1- and putative beta4-adrenoceptors in mouse left atria: no evidence for beta2- and beta3-adrenoreceptor function.
    Oostendorp J; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):134-45. PubMed ID: 10685868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.
    Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of inverse agonism in β-adrenoceptors.
    Taira CA; Monczor F; Höcht C
    Methods Enzymol; 2010; 485():37-60. PubMed ID: 21050910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic infusion of beta-adrenoceptor antagonist and inverse agonists decreases elevated protein kinase A activity in transgenic mice with cardiac-specific overexpression of human beta 2-adrenoceptor.
    Liu X; Callaerts-Vegh Z; Evans KL; Bond RA
    J Cardiovasc Pharmacol; 2002 Sep; 40(3):448-55. PubMed ID: 12198331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-competitive antagonism of beta(2)-agonist-mediated cyclic AMP accumulation by ICI 118551 in BC3H1 cells endogenously expressing constitutively active beta(2)-adrenoceptors.
    Hopkinson HE; Latif ML; Hill SJ
    Br J Pharmacol; 2000 Sep; 131(1):124-30. PubMed ID: 10960078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic implications of beta-adrenergic receptor pharmacodynamic properties.
    Taira CA; Carranza A; Mayer M; Di Verniero C; Opezzo JA; Höcht C
    Curr Clin Pharmacol; 2008 Sep; 3(3):174-84. PubMed ID: 18781904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of Neutral Antagonism and Inverse Agonism in the β
    Calderón JC; Ibrahim P; Gobbo D; Gervasio FL; Clark T
    J Chem Inf Model; 2024 Mar; 64(6):2045-2057. PubMed ID: 38447156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of β
    Saunders SL; Hutchinson DS; Britton FC; Liu L; Markus I; Sandow SL; Murphy TV
    Br J Pharmacol; 2021 Apr; 178(8):1789-1804. PubMed ID: 33506492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity.
    Berg KA; Clarke WP
    Int J Neuropsychopharmacol; 2018 Oct; 21(10):962-977. PubMed ID: 30085126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse agonism and its therapeutic significance.
    Khilnani G; Khilnani AK
    Indian J Pharmacol; 2011 Sep; 43(5):492-501. PubMed ID: 22021988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse agonism: the classic concept of GPCRs revisited [Review].
    Sato J; Makita N; Iiri T
    Endocr J; 2016 Jun; 63(6):507-14. PubMed ID: 26961122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and g(alphao) protein coexpression: evidence for inverse agonism.
    Pauwels PJ; Tardif S; Wurch T; Colpaert FC
    J Pharmacol Exp Ther; 2000 Feb; 292(2):654-63. PubMed ID: 10640303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of inverse agonists in cells overexpressing a constitutively active beta2-adrenoceptor and type II adenylyl cyclase.
    Stevens PA; Milligan G
    Br J Pharmacol; 1998 Jan; 123(2):335-43. PubMed ID: 9489623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligands at beta2-, beta3-, and the low-affinity state of beta1-adrenoceptors block the alpha1-adrenoceptor-mediated constriction in human pulmonary and rat mesenteric arteries.
    Kozłowska H; Schlicker E; Kozłowski M; Siedlecka U; Laudański J; Malinowska B
    J Cardiovasc Pharmacol; 2005 Jul; 46(1):76-82. PubMed ID: 15965358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The odd sibling: features of β3-adrenoceptor pharmacology.
    Cernecka H; Sand C; Michel MC
    Mol Pharmacol; 2014 Nov; 86(5):479-84. PubMed ID: 24890609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of β
    Mori A; Sekito A; Sakamoto K; Ishii K; Nakahara T
    Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):527-533. PubMed ID: 28160015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling and simulation of inverse agonism dynamics.
    Bridge LJ
    Methods Enzymol; 2010; 485():559-82. PubMed ID: 21050936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.